References: Long-term management of alcohol dependence
Anton RF, Latham P, Voronin K, Book S, Hoffman M, Prisciandaro J, et al. Efficacy of Gabapentin for the Treatment of Alcohol Use Disorder in Patients With Alcohol Withdrawal Symptoms: A Randomized Clinical Trial. JAMA Intern Med 2020;180(5):728-36. https://pubmed.ncbi.nlm.nih.gov/32150232/
Apollonio D, Philipps R, Bero L. Interventions for tobacco use cessation in people in treatment for or recovery from substance use disorders. Cochrane Database for Systematic Review 2016;11:CD010274. https://www.ncbi.nlm.nih.gov/pubmed/27878808
Bogenschutz MP, Ross S, Bhatt S, Baron T, Forcehimes AA, Laska E, et al. Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial. JAMA Psychiatry 2022;79(10):953-62. https://pubmed.ncbi.nlm.nih.gov/36001306/
Falk DE, Castle IJ, Ryan M, Fertig J, Litten RZ. Moderators of Varenicline Treatment Effects in a Double-Blind, Placebo-Controlled Trial for Alcohol Dependence: An Exploratory Analysis. Journal of Addiction Medicine 2015;9(4):296-303. https://www.ncbi.nlm.nih.gov/pubmed/26083958
Florez G, Saiz PA, Garcia-Portilla P, Alvarez S, Nogueiras L, Bobes J. Topiramate for the treatment of alcohol dependence: comparison with naltrexone. European Addiction Research 2011;17(1):29-36. https://www.ncbi.nlm.nih.gov/pubmed/20975274
Garbutt JC, Kampov-Polevoy AB, Gallop R, Kalka-Juhl L, Flannery BA. Efficacy and safety of baclofen for alcohol dependence: a randomized, double-blind, placebo-controlled trial. Alcoholism: Clinical and Experimental Research 2010;34(11):1849-57. https://www.ncbi.nlm.nih.gov/pubmed/20662805
Grabski M, McAndrew A, Lawn W, Marsh B, Raymen L, Stevens T, et al. Adjunctive Ketamine With Relapse Prevention-Based Psychological Therapy in the Treatment of Alcohol Use Disorder. American Journal of Psychiatry 2022;179(2):152-62. https://www.ncbi.nlm.nih.gov/pubmed/35012326
Haber PS, Riordan BC. Guidelines for the Treatment of Alcohol Problems. 4th ed. Sydney: Specialty of Addiction Medicine, Faculty of Medicine and Health, The University of Sydney; 2021. https://alcoholtreatmentguidelines.com.au
Harel M, Perini I, Kampe R, Alyagon U, Shalev H, Besser I, et al. Repetitive Transcranial Magnetic Stimulation in Alcohol Dependence: A Randomized, Double-Blind, Sham-Controlled Proof-of-Concept Trial Targeting the Medial Prefrontal and Anterior Cingulate Cortices. Biological Psychiatry 2022;91(12):1061-9. https://www.ncbi.nlm.nih.gov/pubmed/35067356
Heikkinen M, Taipale H, Tanskanen A, Mittendorfer-Rutz E, Lahteenvuo M, Tiihonen J. Real-world effectiveness of pharmacological treatments of alcohol use disorders in a Swedish nation-wide cohort of 125 556 patients. Addiction 2021;116(8):1990-8. https://www.ncbi.nlm.nih.gov/pubmed/33394527
Hurt RT, Ebbert JO, Croghan IT, Schroeder DR, Hurt RD, Hays JT. Varenicline for tobacco-dependence treatment in alcohol-dependent smokers: A randomized controlled trial. Drug and Alcohol Dependence 2018;184:12-7. https://www.ncbi.nlm.nih.gov/pubmed/29324248
Kranzler HR, Feinn R, Morris P, Hartwell EE. A meta-analysis of the efficacy of gabapentin for treating alcohol use disorder. Addiction 2019;114(9):1547-55. https://pubmed.ncbi.nlm.nih.gov/31077485/
Lenaerts E, Mathei C, Matthys F, Zeeuws D, Pas L, Anderson P, et al. Continuing care for patients with alcohol use disorders: a systematic review. Drug and Alcohol Dependence 2014;135:9-21. https://www.ncbi.nlm.nih.gov/pubmed/24314854
Litten RZ, Ryan ML, Fertig JB, Falk DE, Johnson B, Dunn KE, et al. A double-blind, placebo-controlled trial assessing the efficacy of varenicline tartrate for alcohol dependence. Journal of Addiction Medicine 2013;7(4):277-86. https://www.ncbi.nlm.nih.gov/pubmed/23728065
Mayor S. Baclofen is largely ineffective for alcohol use disorders, finds study. BMJ: British Medical Journal 2018;360. https://www.jstor.org/stable/26959118
McCarthy DM, Tomlinson KL, Anderson KG, Marlatt GA, Brown SA. Relapse in alcohol- and drug-disordered adolescents with comorbid psychopathology: changes in psychiatric symptoms. Psychology of Addictive Behaviors 2005;19(1):28-34. https://www.ncbi.nlm.nih.gov/pubmed/15783275
Palpacuer C, Duprez R, Huneau A, Locher C, Boussageon R, Laviolle B, et al. Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta-analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate. Addiction 2018;113(2):220-37. https://www.ncbi.nlm.nih.gov/pubmed/28940866
Penzenstadler L, Machado A, Thorens G, Zullino D, Khazaal Y. Effect of Case Management Interventions for Patients with Substance Use Disorders: A Systematic Review. Front Psychiatry 2017;8:51. https://www.ncbi.nlm.nih.gov/pubmed/28428761
Rombouts SA, Baillie A, Haber PS, Morley KC. Clinical Predictors of Response to Baclofen in the Treatment of Alcohol use Disorder: Results from the BacALD Trial. Alcohol & Alcoholism 2019;54(3):272-8. https://www.ncbi.nlm.nih.gov/pubmed/30977770
Rose AK, Jones A. Baclofen: its effectiveness in reducing harmful drinking, craving, and negative mood. A meta-analysis. Addiction 2018;113(8):1396-406. https://www.ncbi.nlm.nih.gov/pubmed/29479827
Rosner S, Hackl-Herrwerth A, Leucht S, Lehert P, Vecchi S, Soyka M. Acamprosate for alcohol dependence. Cochrane Database of Systematic Review 2010;(9):CD004332. https://www.ncbi.nlm.nih.gov/pubmed/20824837
Rosner S, Hackl-Herrwerth A, Leucht S, Vecchi S, Srisurapanont M, Soyka M. Opioid antagonists for alcohol dependence. Cochrane Database of Systematic Review 2010;(12):CD001867. https://www.ncbi.nlm.nih.gov/pubmed/21154349
Sinclair JD. Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism. Alcohol & Alcoholism 2001;36(1):2-10. https://www.ncbi.nlm.nih.gov/pubmed/11139409
Skinner MD, Lahmek P, Pham H, Aubin HJ. Disulfiram efficacy in the treatment of alcohol dependence: a meta-analysis. PLoS One 2014;9(2):e87366. https://www.ncbi.nlm.nih.gov/pubmed/24520330
Swift RM, Aston ER. Pharmacotherapy for alcohol use disorder: current and emerging therapies. Harvard Review of Psychiatry 2015;23(2):122-33. https://www.ncbi.nlm.nih.gov/pubmed/25747925
Vanderplasschen W, Rapp RC, De Maeyer J, Van Den Noortgate W. A Meta-Analysis of the Efficacy of Case Management for Substance Use Disorders: A Recovery Perspective. Front Psychiatry 2019;10:186. https://www.ncbi.nlm.nih.gov/pubmed/31057432
Wilson K, Halsey A, Macpherson H, Billington J, Hill S, Johnson G, et al. The psycho-social rehabilitation of patients with alcohol-related brain damage in the community. Alcohol & Alcoholism 2012;47(3):304-11. https://www.ncbi.nlm.nih.gov/pubmed/22278316
